Research Paper Volume 16, Issue 10 pp 9188—9203
Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation
Figure 6. Gene set enrichment analysis (GSEA) based on the 50 cancer hallmarks. (A–F) The GSEA analysis between PUS7-high -low groups in BLCA, KIRP, LGG, LIHC, SARC, and THCA. Each panel on the left and right represents the enriched pathways of the PUS7-high and -low groups, respectively.